MCMedicalCodingSoftware
Free trial
XW0U0GA

XW0U0GA: Introduction of Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System into Joints, Open Approach, New Technology Group 10

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduce Vanco/Tobra Tmp Irrig Sys in Jt, Open, New Tech 10

How XW0U0GA is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. XSectionNew Technology: What family of procedure this is
  2. WBody systemWhich system it acts on
  3. 0Root operationThe objective: the verb of the procedure
  4. UBody partThe specific site
  5. 0ApproachHow the site was reached
  6. GDeviceWhat was left in place, if anything
  7. AQualifierA further distinction where one applies

Codes near XW0U0GA

In CMS’s own ordering, which groups codes that differ by only the last character or two, usually the approach, device or qualifier.

  • XW0L3LAIntroduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10
  • XW0M3HAIntroduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10
  • XW0M3JAIntroduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10
  • XW0M3KAIntroduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10
  • XW0M3LAIntroduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10
  • XW0Q316Introduction of Eladocagene exuparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 6
  • XW0Q35CIntroduction of Ifezuntirgene Inilparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 12
  • XW0U0CCIntroduction of Recombinant Human Bone Morphogenetic Protein-2 with Collagen Scaffold into Joints, Open Approach, New Technology Group 12
  • XW0U0GAIntroduction of Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System into Joints, Open Approach, New Technology Group 10
  • XW0U0XBIntroduction of Peptide Enhanced Bone Void Filler into Joints, Open Approach, New Technology Group 11
  • XW0U3XBIntroduction of Peptide Enhanced Bone Void Filler into Joints, Percutaneous Approach, New Technology Group 11
  • XW0U4XBIntroduction of Peptide Enhanced Bone Void Filler into Joints, Percutaneous Endoscopic Approach, New Technology Group 11
  • XW0V0BCIntroduction of Vancomycin-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 12
  • XW0V0P7Introduction of Gentamicin-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 7
  • XW0V3WAIntroduction of AGN1 Bone Void Filler into Bones, Percutaneous Approach, New Technology Group 10
  • XW13325Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5
ICD-10-PCSFY2027